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Cathryn S MellershAbstract
Inherited forms of eye disease are arguably the best described and best characterized of all inherited diseases in
the dog, at both the clinical and molecular level and at the time of writing 29 different mutations have been
documented in the scientific literature that are associated with an inherited ocular disorder in the dog. The dog has
already played an important role in the identification of genes that are important for ocular development and
function as well as emerging therapies for inherited blindness in humans. Similarities in disease phenotype and eye
structure and function between dog and man, together with the increasingly sophisticated genetic tools that are
available for the dog, mean that the dog is likely to play an ever increasing role in both our understanding of the
normal functioning of the eye and in our ability to treat inherited eye disorders. This review summarises the
mutations that have been associated with inherited eye disorders in the dog.Lay summary
Inherited forms of eye disease are arguably the best de-
scribed and best characterized of all inherited diseases in
the dog, at both the clinical and molecular level and at
the time of writing 29 different mutations have been
documented in the scientific literature that are associ-
ated with an inherited ocular disorder in the dog. The
dog has already played an important role in the identi-
fication of genes that are important for ocular deve-
lopment and function as well as emerging therapies for
inherited blindness in humans. Similarities in disease
phenotype and eye structure and function between dog
and man, together with the increasingly sophisticated
genetic tools that are available for the dog, mean that
the dog is likely to play an ever increasing role in both
our understanding of the normal functioning of the eye
and in our ability to treat inherited eye disorders. This
review summarises the mutations that have been associ-
ated with inherited eye disorders in the dog.Introduction
Inherited forms of eye disease are arguably the best de-
scribed and best characterized of all inherited diseases in
the dog, at both the clinical and molecular level. At the
time of writing 29 different mutations have been docu-
mented in the scientific literature that are associated
with an inherited ocular disorder in the dog (Table 1).Correspondence: cathryn.mellersh@aht.org.uk
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unless otherwise stated.Several more conditions have been described very well
at the genetic and clinical level although their causal
mutations remain elusive; however the genetic basis of
many of these will undoubtedly be unraveled over the
coming years, thanks to the increasingly sophisticated
genetic resources that are now available for the dog.
Why have so many inherited eye disorders been de-
scribed in the dog? A principal reason is that the eye is
very accessible, and much of it can be examined in detail
using non-invasive techniques, making it relatively easy to
detect abnormalities, even if they do not impair vision sig-
nificantly. There are clinical screening schemes in place in
many countries that offer dog breeders the opportunity to
screen their dogs, ideally before they are bred from,
for disorders known to be inherited in their breed. One
such scheme is the British Veterinary Association/Kennel
Club/International Sheep Dog Society Eye Scheme that
operates in the United Kingdom (http://www.bva.co.uk/
canine_health_schemes/Eye_Scheme.aspx). This scheme
covers 11 inherited eye disorders in over 50 breeds of
dog. The European College of Veterinary Ophthalmolo-
gists (ECVO) Scheme (http://www.ecvo.org/) is in use in
seven European countries, and individual ECVO Diplo-
mates work in accordance with the scheme in other coun-
tries to control presumed inherited diseases of the eye and
its adnexa. In the United States the Orthopedic Founda-
tion for Animals (OFA) and the American College of Vet-
erinary Ophthalmologists (ACVO) maintain a joint Eye
Certification Registry (ECR). OFA Eye Certification Regis-
try exams are ophthalmic examinations, performed byThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,




Cone-rod dystrophy CRD3 ADAM9 Glen of Imaal terrier [53,54]
Primary open angle glaucoma POAG ADAMTS10 Beagle [147]
Primary lens luxation PLL ADAMTS17 Multiple, mainly terrier breeds [129,132]
Rod cone degeneration RCD4 C2orf71 Gordon Setter, Irish Setter, Tibetan Terrier [30]
Generalised progressive retinal atrophy gPRA CCDC66 Schappendoes [28]
Progressive retinal atrophy PRA CNGB1 Papillon [15,17]
Cone degeneration CD CNGB3 Alaskan malamute [68]
Cone degeneration CD CNGB3 German shorthaired pointer [69]
Dwarfism with retinal dysplasia (oculoskeletal
dysplasia)
DRD2 (OSD2) COL9A2 Samoyed [90]
Dwarfism with retinal dysplasia (oculoskeletal
dysplasia)
DRD1 (OSD1) COL9A3 Labrador retriever [90]
Hereditary cataract HC, EHC HSF4 Staffordshire bull terrier, Boston terrier, French
bulldog
[103]
Hereditary cataract HC HSF4 Australian Shepherd [107]
Collie eye anomaly CEA NHEJ1 Collies [91]
Cone-rod dystrophy NPHP4 Standard wirehaired dachshund [49]
Photoreceptor dysplasia PD PDC Miniature schnauzer [13]
Rod cone dysplasia RCD1 PDE6B Irish setter [2]
Rod cone dysplasia RCD1 PDE6B Sloughi [3]
Rod cone dysplasia RCD3 PDE6A Cardigan Welsh corgi [4]
Progressive rod-cone degeneration PRCD PRCD Multiple breeds [23]
Rod cone dysplasia RCD2 RD3 Collie [7]
Autosomal dominant progressive retinal atrophy ADPRA RHO English mastiff [24]
Congenital stationary night blindness CSNB RPE65 Briard [58,59]
X-linked progressive retinal atrophy XLPRA2 RPGR Mixed breed dogs [18]
X-linked progressive retinal atrophy XLPRA1 RPGR Siberian Husky, Samoyed [18]
Cone-rod dystrophy CORD1 (CRD4) RPGRIP Dachshunds [38]
Early retinal degeneration ERD STK38L Norwegian elkhound [11]
Canine multifocal retinopathy CMR1 VMD2/
BEST1
Great Pyrenees, English Mastiff, and Bullmastiff
dogs
[74]
Canine multifocal retinopathy CMR2 VMD2/
BEST1
Coton de Tulears [74]
Canine multifocal retinopathy CMR3 VMD2/
BEST1
Lapponian Herder [75]
Mellersh Canine Genetics and Epidemiology 2014, 1:3 Page 2 of 14
http://www.cgejournal.org/content/1/1/3ACVO Diplomates, to assess dogs for the presence or ab-
sence of observable hereditary ocular disease. Dogs with
normal exam results receive OFA eye certification num-
bers valid for one year. The three schemes listed above,
and other comparable schemes in place around the world,
differ incrementally from one another in the precise ways
in which they are operated, but they all serve to document
and register dogs affected with, and free from, inherited
eye diseases. Each dog that is clinically examined under
any of these schemes receives a certificate on which the
results of the examination are recorded and the findingsare also recorded in the relevant registry/database, thus
providing a wealth of data regarding the clinical character-
istics and incidence of inherited eye disorders in different
breeds of domestic dog.
Review
Diseases of the retina
Inherited forms of retinal disease are among the best
clinically and genetically characterized genetic condi-
tions in the dog. Retinal disorders can be categorized in
various ways and the way in which they have been
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is certainly not the only way to partition them. Most
methods of classification will, however, broadly take into
account the typical stage of development or age of onset
of the disease, the cells that are typically affected and
whether the disease becomes progressively severe during
the dog’s lifetime or whether it is more or less stationary.
Here the retinal disorders have been broadly divided into
two main categories; the degenerative conditions where
the retina develops normally and then degenerates during
the dog’s lifetime and the developmental or dysplastic dis-
eases in which the retina develops abnormally. It should
be stressed, however, that categorising all retinal disease
into these two broad forms is inevitably an over simplica-
tion in some cases, and that a minority of retinal diseases
have both dysplastic and degenerative characteristics.
Degenerative retinal disorders
The majority of retinal diseases that have been described
in the dog are degenerative conditions. Some degenerative
conditions are characterized by an inevitable increase in
severity over time, invariably culminating in complete loss
of vision, whereas other conditions are characterized by aFigure 1 Categorization of canine retinal disorders. Different mutations
conditions.pathology that does not deteriorate significantly through-
out life. These two broad clinical categories of disease are
described below under the headings progressive and sta-
tionary respectively.
Progressive retinal disorders
Progressive retinal atrophy (PRA) and cone-rod dys-
trophy (CRD) are collective terms for two broad forms
of progressive, bilateral degenerative diseases that affect
the retinal photoreceptor cells.
Progressive retinal atrophy
In general, PRAs are characterized by initial loss of rod
photoreceptor function followed by that of the cones
and for this reason night blindness is the first significant
clinical sign for most dogs affected with PRA. Visual im-
pairment in bright light invariably follows, accompanied
by characteristic changes to the fundus that are visible
upon ophthalmoscopic investigation. Typical changes in-
clude attenuation of the blood vessels of the retina, in-
creased reflectivity of the tapetal layer as a result of
retinal thinning and atrophy of the optic disc. In many
dogs secondary cataracts develop, which might becomein the genes marked with an asterix account for genetically distinct
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use of electroretinography (ERG) for diagnosis. Whereas
most dogs show the same ophthalmoscopic abnormal-
ities the age at which these abnormalities develop varies
considerably between breeds and genetically different
forms of PRA can be broadly divided into early- and
late-onset forms.
Early-onset forms of PRA Early onset forms of the dis-
ease are typically expressed between 2 and 6 weeks of
age, the period of postnatal retinal differentiation in
dogs, and are characterized by the abnormal develop-
ment of the rod and cone photoreceptors. Four well-
characterized, genetically distinct forms of autosomal
recessive, early-onset retinal degeneration are rod-cone
dysplasia type 1 (RCD1), rod-cone dysplasia type 2 (RCD2),
rod-cone dysplasia type 3 (RCD3) and early retinal degen-
eration (ERD) [1]. RCD1, which affects Irish Setters from
approximately 25 days after birth and culminates at about
1 year when the population of rods and cones is depleted,
is caused by a nonsense mutation at codon 807 of the gene
encoding the beta subunit of cGMP phosphodiesterase
(PDE6B), an essential member of the phototransduction
pathway [2]. This mutation was the first responsible for
any form of PRA to be identified in the dog. An 8 base
pair (bp) insertion after codon 816 in the same gene
causes a genetically distinct form of PRA in the Sloughi
which has a later age of onset than the Irish Setter form,
with the first signs of visual impairment not being noticed
until dogs are between 2 and 3 years of age [3]. PRA in
the Cardigan Welsh corgi, termed rod-cone dysplasia 3
(RCD3), is also caused by a mutation in a subunit of
cGMP phosphodiesterase, this time the alpha subunit,
which results in a disease with a comparable age of onset
to RCD1 [4]. In RCD3 affected dogs normal rod-mediated
ERG responses fail to develop, photoreceptor outer seg-
ments do not reach maturity and rod cells are lost by
apoptosis [5]. The genetically distinct RCD2 segregates in
rough and smooth collies [6] and is caused by an insertion
in RD3 that results in a stretch of altered amino acids and
an extended reading frame [7]. Mutations in RD3 have
been associated with retinal degeneration in both humans
and mice [8].
Whereas the early onset forms of PRA, RCD1 and
RCD3, described above, were among the first canine
inherited diseases to be characterized at the molecular
level, the mutation responsible for the similarly early on-
set condition ERD (early-onset degeneration) has only
recently been identified. This condition, which was ori-
ginally described in Norwegian Elkhounds [9], and was
first mapped more than 10 years ago [10] is caused by an
exonic SINE insertion in the gene STK38L [11]. Although
known to have neuronal cell functions STK38L has not
previously been associated with abnormal photoreceptorfunction; being associated with such a disease in dogs
establishes this gene as a potential candidate for similar
diseases in other species, including man.
A different form of early-onset PRA affects Miniature
Schnauzers. Histologically this disease is evident from a
very early age, when the normal retina is nearing the
end of postnatal differentiation, and as it affects both
rods and cones it is termed photoreceptor dysplasia
(PD) [12]. This disease was originally associated with a
missense mutation in phosducin (PDC) [13]. However
additional research has since led to the complete exclu-
sion of phosducin and to the identification of the gene
and mutation that do in fact cause this disease, that is
also known as Type A PRA [14]. Evidence suggests that
Type A PRA is in fact a rare form of PRA in the Mini-
ature Schnauzer and that other, genetically distinct
forms of PRA segregate within the breed, for which the
mutations have yet to be identified [14].
Recently a complex mutation, consisting of the com-
bination of a one basepair deletion and a 6 basepair in-
sertion was identified in exon 26 of CNGB1 in Papillons
with an early onset PRA. The mutation leads to a frame-
shift and a premature stop codon. Affected dogs demon-
strated an early lack of rod function followed by a slow
retinal degeneration, a phenotype comparable to mice
and humans with CNGB1 mutations [15]. CNGB1 com-
bines with CNGA1 to form the rod cyclic nucleotide
gated channel. Previous studies have shown the re-
quirement of CNGB1 for normal targeting of CNGA1
to the rod outer segment [16] and indeed the authors
were able to demonstrate a lack of detectable CNGA1
protein in the rod outer segments of the affected Papil-
lons homozygous for the mutation [15]. The same muta-
tion was also described in Phalene dogs by Ahonen and
collegues [17].
The early onset forms of PRA described above are all
caused by mutations in autosomal genes. In contrast, a
mutation in the X-linked retinitis pigmentosa GTPase
regulator gene (RPGR) causes a very severe form of PRA,
known as XLPRA2, that has been described in mixed
breed dogs [18]. The XLPRA2 mutation is a 2 nucleotide
deletion that results in a frameshift that significantly
changes the predicted peptide sequence by leading to the
replacement of many acidic glutamic acid residues with
basic arginine residues and results in the premature ter-
mination of the protein 71 amino acids downstream. Un-
like the genetically distinct, relatively late onset XLPRA1
that is described below, the phenotype associated with the
frameshift mutation in XLPRA2 is very severe and mani-
fests during retinal development. ERG abnormalities are
evident by 5–6 weeks of age and cell degeneration is
present by 4 months, suggesting the mutant protein has a
toxic gain of function that severely compromises the early
stage of development of the photoreceptors.
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are degenerations of photoreceptors that have completed
normal development. Whereas the genes implicated in
early-onset diseases are those necessary for the correct
development of photoreceptors the genes associated
with later-onset forms of disease are those necessary for
the long-term maintenance and function of these cells.
Progressive rod cone degeneration (PRCD) is a late-
onset form of PRA that affects multiple breeds. Prior to
characterization of this disease at the molecular level, ele-
gant interbreed crosses were undertaken to determine that
the phenotypically similar diseases that were segregating
in multiple breeds, including the miniature poodle, the
English and American cocker spaniels, the Labrador re-
triever, the Australian cattle dog, the Nova Scotia duck
tolling retriever and the Portugese water dog, were in fact
allelic [19,20]. However, when PRCD-affected dogs were
mated to PRA-affected dogs of the Border Collie, Basenji
and Italian greyhound breeds the progeny were normal,
indicating these breeds are affected by genetically distinct
forms of disease. The PRCD locus was mapped to a large
region on CFA9 in 1998 [21] before the canine genome
sequence was available and while tools with which to
investigate the canine genome were relatively unsophisti-
cated. However, the fact that a genetically identical disease
segregated in so many breeds proved to be invaluable as
it allowed the use of linkage disequilibrium mapping
across affected breeds to considerably narrow the PRCD-
associated region [22]. This led to the eventual identifica-
tion of a single nucleotide substitution in the second
codon of a previously unknown gene that is now known
to be the cause of PRCD in at least 18 different breeds
[23]. Intriguingly, an identical homozygous mutation was
identified in a human patient with recessive retinitis pig-
mentosa, the human equivalent of PRA, and established
the novel retinal gene, PRCD, as an important gene for the
maintenance of rod photoreceptor structure and function
across species.
A genetically distinct, late onset PRA has been de-
scribed in the English Mastiff. This disease is unique, to
date, among canine inherited retinopathies in that it is
inherited as an autosomal dominant disease, and is
caused by a single non-synonymous C → G transversion
at nucleotide 11 of rhodopsin (RHO) that changes Thr-4
to Arg (T4R). Dogs carrying the RHO mutation have
normal photoreceptor-specific ERG function at 3 to
6 months of age but by 13 months these responses are
abnormal. In young affected dogs retinal structure, rhod-
opsin expression and photoreceptor activation is normal;
disease progression is characterized by regions of initial
focal photoreceptor degeneration surrounded by areas of
structurally normal retina, which interestingly is very
similar to the phenotypes of humans with RHO muta-
tions [24]. A characteristic component of the phenotypeassociated with T4R mutation is the dose–response rela-
tionship that has been demonstrated between light ex-
posure and the early alterations in retinal tissue that
occur in affected animals. Highest doses of light cause
rapid loss of neurons, reaching complete degeneration of
photoreceptors in < 4 weeks whereas the lowest doses of
light exposure enable mechanisms acting over a time
scale of weeks to months to repair the abnormal alter-
ations resulting from neuronal stress [25]. This muta-
tion, originally identified in the English mastiff, has also
been identified in PRA-affected bull mastiffs but has not
been identified in any other breeds to date [26].
A different late onset form of autosomal recessive gen-
eralised PRA has been described in Schapendoes where
the age of onset is typically between 2–5 years. During
the early stages of the disease affected dogs become
night-blind, lacking the ability to adjust their vision to
dim light; later their daytime vision also fails. This
process of complete photoreceptor degeneration takes
up to 2 years [27]. The causal mutation for the disease
has been shown to be a single bp insertion in exon 6 of
the recently discovered gene coiled-coil domain contain-
ing 66 (CCDC66) that leads to a stop codon. CCDC66 is
evolutionarily conserved in different vertebrate species
and exhibits a complex pattern of differential RNA spli-
cing resulting in various isoforms in the retina. Immuno-
histochemically, CCDC66 protein is detected mainly in
the inner segments of photoreceptors in mouse, dog,
and man although the retinas of affected Schapendoes
have been shown to lack CCDC66 protein [28].
A different mutation in RPGR from that associated
with XLPRA2 (described above) is responsible for a sex-
linked form of late-onset form PRA that was originally
described in the Siberian Husky [29] known as XLPRA1.
The mutation, which has also been identified in the
Samoyed, is a five nucleotide deletion that causes a
frameshift and an immediate premature stop; the trun-
cated protein lacks 230C-terminal amino acids which
causes a slight decrease in the isoelectric point [18]. The
photoreceptors of dogs that carry this mutation develop
normally, in contrast to those of dogs with XLPRA2,
and remain morphologically and functionally normal
until young adulthood, indicating the C-terminal of the
RPGR protein is not essential for functional and struc-
tural differentiation of rods and cones.
Recently a frameshift mutation was identified in C2orf71
that causes an autosomal recessive form of late onset PRA
in the Gordon and Irish Setters [30]. The average age of
onset in the dogs studied was approximately 10 years of
age. This variant was homozygous in 19 of 21 PRA cases
and was at a frequency of approximately 0.37 in the
Gordon Setter population. Approximately 10% of cases in
this study (2 of 21) were not associated with the C2orf71
mutation, indicating that PRA in this breed is genetically
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variant is also present in a number of Irish Setter dogs
with PRA and has an estimated allele frequency of 0.26 in
the breed. The function of C2orf71 remains unknown, but
it is important for retinal development and function and
has previously been associated with autosomal recessive
retinitis pigmentosa in humans [31-34]. The form of PRA
associated with the mutation in C2orf71 has been termed
RCD4, for rod-cone degeneration 4, to distinguish it from
other forms of rod-cone degeneration [30]. The mutation
has also been found in Tibetan Terriers affected with PRA
(Mellersh and Downs, unpublished).
All the progressive, late-onset retinal disorders de-
scribed behave, more or less, as single-gene conditions,
caused by highly penetrant mutations. There is, however,
some evidence that environmental modifiers may play a
role in some of these diseases, causing phenotypic vari-
ation between and within breeds [20].
Cone-rod degenerations
Cone-rod dystrophies are disorders predominantly of
cones, with rods becoming affected later. CRDs have
ophthalmoscopic changes that are very similar to those
of PRA and detailed ERG studies that measure both
cone and rod-specific responses are required to distin-
guish between the two types of condition. For this rea-
son several disorders have been initially described as
PRAs to be later re-classified when extensive ERG inves-
tigations have been undertaken.
One such disorder is a form of retinal degeneration
that has been described in the Miniature longhaired
dachshund (MLHD). The disease was originally de-
scribed as an early-onset, autosomal recessive PRA with
all affected dogs within an inbred research colony dis-
playing ophthalmologic abnormalities that were detect-
able by ERG by six weeks of age and 25 weeks by
fundoscopy and becoming blind by the time they were
2 years of age [35]. A subsequent electroretinography
study identified an initial reduction of the cone photo-
receptor function which led to the condition being re-
classified as a cone-rod dystrophy (CRD), rather than a
rod-led PRA, and the disease was termed CORD1 for
cone-rod degeneration 1 [36]. The same condition has
also been referred to as CRD4 by others, for cone-rod
degeneration 4 [20]. Later findings by Lheriteau and co-
workers were also consistent with the condition being a
CRD [37]. Using the same colony of dogs CORD1 was
mapped to a large region on CFA15 and a mutation in
RPGRIP1 was identified that co-segregated completely
with CORD1 in the research colony [38]. The mutation
is a 44 bp insertion of a A29 tract flanked by a 15 bp du-
plication in exon 2 of the gene, that creates a frameshift
and introduces a premature stop codon early in exon 3.
Mutations in RPGRIP1 have been associated with Lebercongenital amaurosis (LCA) [39], retinitis pigmentosa
(RP) [40] and CRD [41] in humans, as well as inherited
retinal abnormalities in mice [42] which suggests it plays
an important role in visual function. The gene product’s
precise role is not currently understood but it is thought
to anchor regulatory complexes at the photoreceptor
connecting cilium, which acts as a bridge between the
inner and outer segments of photoreceptor cells [43] as
well as having functions in disk morphogenesis [42] and
in the structure of the ciliary axoneme [44]. RPGRIP1
also interacts with NPHP4, a gene that has been associated
with a genetically distinct form of early-onset CRD segre-
gating in the standard wire-haired variety of Dachshund
[45-49]. Within the research colony of MLHDs there was
complete correlation between the RPGRIP1 genotype and
phenotype of the dogs with respect to their CORD1
phenotype whereas in the pet MLHD population this was
not the case [50]. Outside of the colony there was consid-
erable variation in the age of onset of retinal degeneration
in dogs that were homozygous for the RPGRIP1 insertion
(termed RPGRIP1-mutant), which has also been identified
in other breeds, including the English springer spaniel
(ESS) and the Beagle. In a study of a small number of
RPGRIP1-mutant Beagles ERG cone responses were un-
detectable whereas rod responses were variable between
dogs, and between eyes of the same dog [50]. In the same
study all RPGRIP1-mutant MLHDs showed reduced cone
responses, even in the absence of ophthalmoscopic abnor-
malities, a finding that has also been corroborated by
Busse and co-workers [51]. Together these findings sug-
gest that additional mutations are involved which modify
the age of onset of ophthalmoscopic abnormalities asso-
ciated with the RPGRIP1 mutation. Because the original
research colony used was developed from a very small
number of dogs it is a real possibility that the colony was
fixed for these additional loci which, therefore, went un-
detected until the more outbred pet population was inves-
tigated. The mutation in NPHP4 described above, that
causes an early onset cone-rod dystrophy in standard
wire-haired dachshunds [49] was not present in the dachs-
hunds studies by Miyadera, enabling that mutation to be
excluded. A recent association study using RPGRIP1-
mutant MLHDs that had either early or late onset cord1
has indeed revealed a second locus that segregates with
early-onset disease [52], indicating early onset CRD in
MLHDs is more likely to be a digenic condition, and that
the RPGRIP1 insertion alone causes a late onset CRD,
although ERG abnormalities may be detected early in life.
Another form of canine cone-rod dystrophy to be
characterized at the molecular level is crd3, for cone-rod
dystrophy 3, that segregates in the Glen of Imaal terrier.
This disease becomes evident ophthalmoscopically in af-
fected dogs as young as 3 years of age, and progresses to
end-stage retinal degeneration over several years. Very
Mellersh Canine Genetics and Epidemiology 2014, 1:3 Page 7 of 14
http://www.cgejournal.org/content/1/1/3recently the causal mutation has been identified by two
research groups almost simultaneously, as a large gen-
omic deletion of ADAM9 (A Disintegrin And Metallo-
protease domain, family member 9) that removes exons
15 and 16 of the ADAM9 transcript [53,54] and gener-
ates a premature stop codon that is predicted to result
in a truncated protein that lacks critical domains. This
finding established CRD3 as a true orthologue, and a po-
tentially useful model, of the similar human condition
CORD9 in which four distinct ADAM9 mutations have
been found [55].
Stationary retinal disorders
The forms of both PRA and CRD described above are
all inherited retinopathies that are characterized by in-
creasing severity and decreasing visual function over
time. Progressive retinal changes during the dog’s life-
time invariably lead to complete blindness.
The first non-progressive retinopathy to be well-
characterized was described in the Swedish Briard by
Narfstrom and colleagues [56] as stationary and congeni-
tal, resulting in it being termed congenital stationary night
blindness (CSNB). Since the initial report the disease has
also been described as having a progressive component
leading to it also being called a hereditary retinal dys-
trophy [57]. However CSNB and hereditary retinal dys-
trophy have since both been shown to be caused by a four
nucleotide deletion in exon 5 of the RPE65 gene, indicat-
ing they are genetically identical conditions [58,59]. RPE65
is involved in the conversion of all-trans-retinoids to
11-cis-retinoids and in its absence the visual cycle is inter-
rupted, resulting in a lack of visual pigment [60]. This ca-
nine disease has a very characteristic clinical phenotype;
affected dogs have profound visual impairment present
from at least 5–6 weeks of age, but remain ophthalmosco-
pically normal, at least for the first 3–4 years of life. Older
dogs may show subtle retinal abnormalities indicative of a
slowly progressive retinal degenerative process. Both cone
and rod mediated ERG responses are highly abnormal,
probably due to a combination of responses from rods
and possibly cones with very reduced sensitivity [58]. It
was the unique absence of visual function in dogs with
healthy rod photoreceptors that was observed in CSNB-
affected dogs that led to landmark studies in the field of
retinal gene therapy. Subretinal injections of adeno-
associated virus vectors expressing RPE65 resulted in res-
toration of rod photoreceptor function and improved
visual function, first in dogs [61,62] and subsequently in
humans [63-65].
Cone degeneration (CD) is also different from other
progressive disorders in that early-onset cone degener-
ation occurs in the absence of the subsequent rod de-
generation that characterizes cone-rod dystrophies. In
cd, which was originally described in Alaskan Malamutes[66], affected puppies develop day-blindness and photo-
phobia between 8 and 12 weeks of age, when retinal
development is normally completed in dogs, although
these clinical signs only occur in bright light and the
dogs remain ophthalmoscopically normal throughout
their entire lives. Cone function starts to deteriorate by
the age of 6 – 12 weeks and is unrecordable in adult
dogs [67]. Rod photoreceptors, however, remain func-
tionally and structurally normal throughout the animal’s
life. A large genomic deletion that removes all exons of
CNGB3, the gene that encodes the β subunit of the cone
cyclic nucleotide-gated cation channel, has been identified
in CD-affected Alaskan Malamute-derived dogs, although
there is evidence that the condition might be genetically
heterogeneous in this breed as some dogs have been iden-
tified with clinical signs of day blindness that lack the
CNGB3 deletion [68]. A missense mutation in the same
gene has been detected in German Shorthaired Pointers
affected with a clinically identical allelic disorder [69].
These findings established CD as an orthologue of human
achromatopsia, a condition also known as rod monochro-
macy or total congenital colour blindness, that shares
many of its clinical features with CD and has also been as-
sociated with mutations in CNGB3 [70,71]. The potential
of these orthologues has recently been demonstrated by
the successful restoration of cone function and associated
photopic vision in both of the canine achromatopsia
models by gene replacement therapy [72].
Another inherited retinal disorder that is generally non-
progressive is canine multifocal retinopathy (CMR), a dis-
ease that has been recognized in several breeds, particularly
Great Pyrenees, Coton de Tulear, English Mastiff and
Bullmastiff [73,74]. Ophthalmoscopic changes are usually
evident in affected dogs before the age of around 4 months
and are characterized by multifocal areas of retinal eleva-
tion that contain subretinal accumulation of serous fluid.
Retinal elevations can remain static for several years,
whereas multifocal outer retinal atrophy is often seen in
older animals. Several different variants in the Bestrophin
gene (BEST1 (alias VMD2)) have been identified as likely
causal mutations for CMR in the dog. In Great Pyrenees,
English Mastiff, and bullmastiff dogs, a C73T mutation in
exon 2 causes a premature translation termination that
limits the open-reading frame to 25 codons, compared
with 580 codons in the wild-type mRNA (cmr1) and in
Coton de Tulears a G482A transition changes an evolu-
tionarily conserved glycine residue to aspartic acid (cmr2).
In Lapponian Herders two coding changes have been
described in CMR affected dogs; a deletion at nucleotide
position 1,388 (c1388del) and a substitution at nucleo-
tide position 1,466. The c1388del results in a frame shift
(Pro463fs) introducing a new stop codon at amino acid
490 and the G1466T substitution by itself leads to a con-
servative change in the amino acid sequence (Gly489Val),
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marginal significance. In combination with the C1388del,
however, the G1466T substitutions results in an additional
stop codon at amino acid position 489 within the shifted
reading frame (Gly489X). Since the mutations have only
been found in complete linkage disequilibrium, the authors
conclude that the combination of changes results in the
disease they refer to as cmr3 [75].
These mutations establish CMR as a novel animal
model for Best macular dystrophy (BMD) in humans, an
autosomal dominant, childhood retinal disease also
caused by mutations in the Bestrophin gene [76,77].
Developmental diseases
Retinal dysplasia is the term used to denote disorderly
proliferation and imperfect differentiation of the devel-
oping retina and can be subdivided into focal, multifocal,
geographic and total types. Focal and multifocal types
manifest as linear folds and ‘rosettes’ of tissue in the
inner (sensory) retinal layer whereas in geographic forms
there are larger areas of defective retinal development
that appear as large irregular or horseshoe-shaped areas
of mixed hyper- or hyporeflectivity in the central retina.
Total or generalized forms of retinal dysplasia have been
described as an inherited trait in several breeds, includ-
ing the Bedlington terrier [78], Sealyham terrier [79],
Labrador retriever [80] and the Yorkshire terrier [81]
and are associated with complete detachment of the ab-
normal neuroretina from the retinal pigment epithelium
that results in blindness of affected eyes. All forms of
retinal dysplasia are congenital and non-progressive. Ret-
inal dysplasia appears to be inherited as an autosomal
trait, at least in those breeds where sufficient numbers of
individuals have been studied to reliably estimate the
mode of inheritance [82-84]. The genetics of isolated or
non-syndromic forms of retinal dysplasia have not been
characterized at the molecular level in any breeds to
date and no mutations have been associated with this
condition.
Forms of syndromic retinal dysplasia have been reported
in the Labrador retriever [85-87] and the Samoyed [88].
Homozygous affected dogs had short-limbed dwarfism
and a range of ocular changes characterized by complete
retinal detachment and cataract whereas heterozygous
dogs had only focal or multifocal retinal lesions [85,86].
Breeding studies determined that these two disorders
are non-allelic [89] and they were termed DRD1 (dwarf-
ism with retinal dysplasia type 1, Labrador retriever)
and DRD2 (Samoyed), respectively (these conditions
have also previously been referred to as OSD1 and
OSD2 for oculoskeletal dysplasia). Mutations have re-
cently been associated with both disorders; a 1-base pair
insertional mutation in exon 1 of COL9A3 is associated
with DRD1 and a 1,267-bp deletion in the 5’ end ofCOL9A2 co segregates with DRD2. Both mutations
affect the COL3 domain of their respective genes, the
expression of which are both reduced in affected
retinas [90].
Another complex congenital defect of the retina is collie
eye anomaly (CEA), although retinal involvement is sec-
ondary to the primary ocular defects associated with this
disorder. The primary phenotypic element of the disorder
is regional hypoplasia of the choroid, the highly vascular
layer underlying the retina. Associated retinal lesions,
known as colobomas are often detectable ophthalmosco-
pically, as are tortuous retinal vessels and multiple retinal
folds in a minority of cases [91]. CEA, which segregates in
several herding breeds with Collie ancestry, was mapped
to a large region of CFA37 that included over 40 genes
[92]; subsequently the fact that the disorder segregates in
multiple, closely related breeds was used to reduce the size
of the critical disease-associated region and pinpoint the
causal mutation to a 7.8 kb intronic deletion in the NHEJ1
gene, which spans a highly conserved binding domain to
which several developmentally important genes bind [91].
The precise mechanism by which the deletion causes CEA
has not however been established to date.
Hereditary cataract
The lens is the transparent, biconvex, avascular structure
in the anterior segment of the eye that is partly respon-
sible for the refraction of light to be focused on the ret-
ina. The lens consists of a nucleus, cortex and capsule
and is suspended by many dense zonular ligaments
which are attached to the capsule and connect between
the ciliary body and the lens equator. Transparency is a
crucial property of the lens which is achieved, in part, by
the absence of light-scattering organelles within the lens
fibres. New lens fibres are generated from the equatorial
cells of the lens epithelium, which elongate, synthesize
crystallin and finally lose their nuclei as they become
mature lens fibres. The crystallins, which make up over
90% of the proteins in the lens, are specially adapted to
contribute to the maintenance of transparency by form-
ing soluble, high-molecular weight aggregates that need
to stay in solution for the duration of an individual’s life.
Cataracts are simply defined as opacities of the lens
and can develop for a variety of reasons, including ad-
vanced age and the secondary effects of other diseases
such as diabetes or progressive retinal atrophy, and
trauma. Primary or hereditary cataracts (HC) are com-
mon among dogs and are a leading cause of blindness.
HC has been reported in as many as 97 different breeds
[93,94], with around 60 breeds being reported to be at
increased risk compared to mixed-breed dogs [95]. Her-
editary cataracts reported in different breeds vary with
respect to their anatomic position within the lens, their
age of onset and their progressive or stationary nature,
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breed specificity. Despite the large number of breeds af-
fected by HC only a single gene, the transcription factor
HSF4, has been implicated in the development of cata-
racts in dogs to date. HSF4 belongs to a family of heat
shock transcription factors that regulate the expression
of heat shock proteins in response to different stresses,
such as oxidants, heavy metals, elevated temperatures
and bacterial and viral infections [96]. Different muta-
tions in HSF4 have been reported to cause both human
autosomal dominant and recessive cataracts [97-99] and
studies in mice have shown HSF4 is required for normal
fibre cell differentiation during lens development [100,101].
Disruption of the gene leads to the development of cata-
racts via multiple pathways, including the down-regulation
or loss of post-translational modification of different crys-
tallin proteins [102]. A single recessive nucleotide insertion
in exon 10 of the gene (CFA5 g.85286582_85286583insC),
that causes a frameshift and introduces a premature stop
codon, is responsible for an early onset, bilaterally sym-
metrical and progressive form of HC in the Staffordshire
bull terrier [103]. This cataract starts to develop from a
few months of age and invariably progresses to total cata-
ract within 2–3 years if left untreated [104]. The mutation
is shared by the Boston terrier, in which it causes the clin-
ically identical early-onset hereditary cataract (EHC), one
of two genetically distinct forms of cataract known to
affect this breed [104,105]. The mutation associated with
the clinically more variable, late-onset hereditary cataract
(LHC) in this breed has yet to be identified [106]. The
same mutation has also been identified in a small num-
ber of French bulldogs with a clinically identical cata-
ract (Mellersh, unpublished).
A single nucleotide deletion at the same position in
HSF4 (CFA5 g.85286582delC) has also been associated
with HC in the Australian Shepherd. The form of cataract
caused by the insertion identified in the Staffordshire bull
terrier and related breeds has a recessive and highly pene-
trant mode of inheritance, is early onset, highly progressive
and uniform. In contrast, the form of cataract observed in
the Australian Shepherd, caused by the deletion described
above, has a dominant, or co-dominant mode of inherit-
ance, is not completely penetrant and is typically associ-
ated with a posterior polar subcapsular cataract that also
has a variable age of onset. It is highly likely that other
mutations associated with the development of cataracts
are co-segregating in the Australian Shepherd popula-
tion because not all the dogs with bilateral posterior
polar subcapsular cataract carried a copy of the HSF4
deletion [107].
HSF4 has been excluded from involvement in the de-
velopment of HC in a long list of breeds, including the
Alaskan Malamute, American Cocker spaniel, Bichon
Havanais, Belgian Shepherd Tervueren and Groenendael,Dachshunds, English Cocker spaniels, English Miniature
Terrier, Finnish Lapphund, Golden retriever, Griffon
Bruxellois, Kromfohrlander, Jack Russell terrier, Lapponian
Herder, Miniature Schnauzer, Miniature Pinscher, Nova
Scotia Duck Tolling Retriever, Rottweiler, Samoyed,
Schnauzer, and Tibetan Mastiff [103,107-111]. The paucity
of canine cataract mutations that have been reported in
the literature, compared to those associated with, for ex-
ample, inherited retinal degenerations in the dog, is testa-
ment to the fact that HC is probably a genetically complex
disorder in most breeds of dog and studies to date have
not included the analysis of sufficient numbers of cases
and controls to identify DNA variants associated with the
disease. A recessive mode of inheritance has been sug-
gested for congenital cataracts and microphthalmia in the
Miniature Schnauzer [112] as well as cataracts in the
Entlebucher mountain dog [113], the Bichon Frise [114]
and the American Cocker spaniel [115]. In contrast, an
autosomal dominant mode of inheritance with a high de-
gree of penetrance has been suggested for the pulverulent
(dust-like) form of cataract observed in the Norwegian
Buhund [116] and autosomal dominant with variable
penetrance has been suggested for inherited posterior
polar subcapsular cataracts in the Labrador and Golden
retriever [117], although current anecdotal evidence indi-
cates that in the Labrador cataracts could also be inherited
as an autosomal recessive trait. Evidence of inheritance
has been reported for a handful of other breeds, including
the Leonberger, Jack Russell terrier and Chow chow, al-
though the precise mode of inheritance has rarely been
identified [111,118,119].
Primary lens luxation
Primary lens luxation (PLL) is not a disease of the lens
itself, but rather an inherited deterioration of the lens
suspensory apparatus, the zonule, which is a system of
fibres that suspend the lens from the ciliary body, main-
taining it within the visual axis and in contact with the
anterior surface of the vitreous body. In dogs affected
with PLL ultrastructural abnormalities of the zonular fi-
bers are already evident at 20 months of age [120] long
before the lens luxation that typically occurs when the
dogs are 3 to 8 years old, as a result of degeneration
and breakdown of the zonules which cause the lens to
be displaced from its normal position within the eye
[121-124]. In the majority of cases the dislocated lens
will pass into the anterior chamber where its presence is
likely to cause acute glaucoma. The condition has been
recognized as a canine familial disorder for more than
100 years [125,126] and is encountered at high fre-
quency in several terrier breeds and in some other
breeds with probable terrier co-ancestry [121-124,127].
PLL is recessively inherited in the Tibetan terrier [127]
and inheritance has been suggested to be recessive in
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it has been studied [128]. A mutation in ADAMTS17
has been described as the cause of PLL in three breeds,
the Miniature Bull terrier, the Lancashire Heeler and the
Jack Russell terrier. The mutation is a G→A substitution
at c.1473 + 1, which destroys a splice donor recognition
site in intron 10 and causes exon skipping that results in
a frameshift and the introduction of a premature termin-
ation codon [129]. The great majority of PLL-affected
dogs are homozygous for the mutation, but a small mi-
nority are heterozygous, leading to speculation that car-
riers, of some breeds at least, might be at increased risk
of developing the condition compared to dogs that are
homozygous for the wildtype allele [129]. ADAMTS17 is
one of 29 known mammalian members of the ADAMTS
family of genes that encode secreted metalloproteases
that proteolytically modify extracellular structural pro-
teins. Mutations in a variety of ADAMTS genes have
been associated with a diverse set of human diseases
including Ehlers-Danlos syndrome [130] and Weill-
Marchesani syndrome [131]. The canine ADAMTS17
splice site mutation is shared by at least 17 different
breeds, many of which are terriers or terrier-type breeds,
but some of which have more diverse origins [132].
Some breeds that are known to be at increased risk of
PLL, such as the Border Collie, do not carry the same
ADAMTS17 mutation as the terrier breeds, indicating
their form of the disease must be genetically distinct
although clinically similar [132].
Other conditions
The diseases of the lens and retina described above rep-
resent the overwhelming majority of inherited eye condi-
tions in the dog for which causal mutations have been
identified. Many other ocular conditions have been re-
ported to be more common in certain breeds than
others, which is indicative that they have a genetic com-
ponent. However, a rigorous estimate of the mode of in-
heritance has been undertaken for relatively few of these
conditions. To list comprehensively all the eye condi-
tions that have been reported in dogs is outside the
scope of this review, so the remainder of conditions de-
scribed is restricted to those conditions for which an es-
timate of the mode of inheritance or the heritability has
been reported.
Glaucoma
Glaucoma is the term used to describe a group of condi-
tions that result in increased intraocular pressure, with
damage to the retinal ganglion cells and their axons,
leading to vision loss and blindness. Glaucoma is com-
monly divided into congenital, primary and secondary
types, depending on the aetiology of the condition. Con-
genital glaucoma is rare in the dog [133] and secondaryglaucoma, which is the most common form of the con-
dition observed in the dog, arises as result of antecedent
or concurrent ocular disease, so is not itself inherited, al-
though the primary, causal condition might be. Primary
glaucoma occurs in the absence of any other ocular dis-
ease, and, therefore, is presumed to have a genetic com-
ponent in most breeds. Primary glaucoma can occur in
the presence (angle closure glaucoma) or absence (open
angle glaucoma) of an abnormal, narrowed or closed
opening into the ciliary cleft, which prevents the efficient
drainage of aqueous humour from the anterior chamber
of the eye, via the iridocorneal angle through openings
between the pectinate fibres. Goniodysgenesis is the
most common cause of primary glaucoma in dogs, and
refers to the presence of abnormal, irregularly-shaped
or imperforate sheets of pectinate fibres. Glaucoma has
been reported to be more prevalent than average in
several breeds, including the Flat Coated Retriever,
American Cocker spaniel, the Bassett Hound, the Shar
Pei, the Norwegian Elkhound and the Boston terrier
[134-137]. A strong and significant correlation between
goniodysgenesis and glaucoma was reported in the Great
Dane, and the same study reported a high heritability for
goniodysgenesis, suggesting glaucoma may be heritable
in this breed [138]. A similarly significant association
has been reported between pectinate ligament dysplasia
and adult-onset primary glaucoma in the Flatcoated re-
triever, for which the heritability was estimated to be
approximately 0.7 [139,140]. To date no mutations have
been identified that are associated with angle closure glau-
coma in any breed of dog although the first glaucoma-
associated locus has recently been identified in Dandie
Dinmont Terriers [141].
Autosomal recessive, primary open-angle glaucoma
(POAG) has been very well characterized in the Beagle
[142-146] and a Gly661Arg variant in ADAMTS10 has
been associated with the condition in Beagles that devel-
oped elevated intraocular pressure from 8 to 16 months
of age, due to increased resistance to outflow of aqueous
humour despite normal appearing open iridocorneal
angles [147].Persistent hyperplastic primary vitreous
Persistent hyperplastic primary vitreous (PHPV) is a
congenital, non-progressive condition which results from
the abnormal regression of the foetal hyaloid vascula-
ture. The condition is rare but is seen more commonly
in Staffordshire bull terriers in which pedigree analysis
supports a hereditary etiology for the condition but is
insufficient to determine the exact mode of inheritance,
[148,149]. PHPV and persistent hyperplastic tunica vas-
culosa lentis (PHTVL) has also been described in detail
in the Doberman [150].
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At the time of writing 29 different mutations have been
associated with inherited eye disease in the domestic
dog, and more are likely to have been identified by the
time this review goes to press. This number far exceeds
those associated with any other category of disease,
meaning that inherited eye diseases are arguably better
understood, at both the clinical and genetic level, than
any other category of canine disease. The dog has
already played an important role in emerging therapies
for inherited blindness in humans and similarities in dis-
ease phenotype and eye structure and function between
dog and man, together with the increasingly sophisti-
cated genetic tools that are available for the dog, mean
that the dog is likely to play an ever increasing role in
both our understanding of the normal functioning of the
eye and in our ability to treat inherited eye disorders.
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